About ARCH
ARCH was formally incorporated in December 2024, backed by TÜBİTAK. But the story behind it spans nearly two decades.
Our co-founders share a 20-year relationship and 15 years of hands-on experience in health and medical devices, at times as collaborators, at times as competitors. They held clinical and senior management roles ranging from clinical specialist to general manager, and played an active part in bringing Turkey's first high-technology vascular devices to market: atherectomy, pharmacomechanical thrombectomy, and PTA balloon systems.
After 15 years focused on treatment, they turned their attention to what they had long seen as a missing piece: long-term health. The result is ARCH, a patented, one of a kind circulatory health technology.
State Recognition
Backed by TÜBİTAK
In December 2024, we became a TÜBİTAK-supported venture, receiving both the Excellence Seal and direct state investment from Turkey's national science and technology authority. This recognition reflects the scientific rigor and real-world potential at the core of what we're building.
Academic Ecosystem
Rooted in Turkey's Top Universities
We operate within the ecosystems of Boğaziçi University and Istanbul Technical University, two of Turkey's most established and respected academic institutions. As members of their incubation centers and technoparks, which admit only a competitive few, we are embedded at the heart of Turkey's innovation infrastructure.
We took the stage at BigBang Startup Challenge, one of Turkey's largest entrepreneurship platforms, winning $65,000. We are also a member of ITU Çekirdek, one of the world's leading university-based accelerator programs.
View ARCH on BigBang Startup Challenge
Global Stage
Featured at CES
Earlier this year, we presented ARCH at CES, the world's foremost technology showcase, introducing our product to the global technology ecosystem. Sharing a stage with the most innovative companies on the planet reinforced what we've always believed: the problem we're solving is universal, and the solution we're building is ready for the world.
